The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Align Technology Inc

Nasdaq: ALGN
Last

(U.S.) $94.60

Today's change+0.16 +0.17%
Updated September 28 4:00 PM EDT. Delayed by at least 15 minutes.
 

Align Technology Inc

Nasdaq: ALGN
Last

(U.S.) $94.60

Today's change+0.16 +0.17%
Updated September 28 4:00 PM EDT. Delayed by at least 15 minutes.

Align Technology Inc up (U.S.)$0.16

Align Technology Inc closed up Wednesday by (U.S.)$0.16 or 0.17% to (U.S.)$94.60. Shares have lost 0.78% over the last five days, but sit 2.37% below their 52-week high. This security has outperformed the S&P 500 by 55.58% during the last year.

Key company metrics

  • Open(U.S.) $94.54
  • Previous close(U.S.) $94.44
  • High(U.S.) $94.70
  • Low(U.S.) $93.59
  • Bid / Ask(U.S.) $75.05 / (U.S.) $0.00
  • YTD % change+43.66%
  • Volume318,101
  • Average volume (10-day)759,512
  • Average volume (1-month)742,801
  • Average volume (3-month)704,249
  • 52-week range(U.S.) $54.64 to (U.S.) $96.90
  • Beta1.87
  • Trailing P/E45.99×
  • P/E 1 year forward41.48×
  • Forward PEG1.82×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $2.06
Updated September 28 4:00 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+17.67%

Based on its net profit margin of 17.67%, Align Technology Inc is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX1.19%Sector:HealthcareIndustry:Medical Equipment, Supplies & Distribution
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2016Q1/2016Q4/2015Q3/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201606/30/2016Mar 31, 201603/31/2016Dec 31, 201512/31/2015Sep 30, 201509/30/2015
Revenue269239230208
Total other revenue--------
Total revenue269239230208
Gross profit205181173158
Total cost of revenue64585750
Total operating expense204185171170
Selling / general / administrative121112100102
Research & development19151418
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)----0--
Other operating expenses, total--------
Operating income65535938
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax65536036
Income after tax50414928
Income tax, total1512119
Net income50414928
Total adjustments to net income--------
Net income before extra. items50414928
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items50414928
Inc. avail. to common incl. extra. items50414928
Diluted net income50414928
Dilution adjustment--------
Diluted weighted average shares81818181
Diluted EPS excluding extraordinary itemsvalue per share0.620.500.600.34
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share0.620.500.600.34